Rigel Pharmaceuticals (RIGL) Interest Coverage Ratio (2010 - 2026)
Rigel Pharmaceuticals' (RIGL) quarterly Interest Coverage Ratio came in at 5.06 in Q1 2026, up 507.32% year-on-year from 0.83 in Q1 2025, and up 50.55% quarter-over-quarter from 3.36 in Q4 2025.
Rigel Pharmaceuticals (RIGL) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Interest Coverage Ratio history runs 17 years deep, the most recent figure standing at 5.06 for Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 507.32% year-over-year to 5.06 in Q1 2026; TTM through Mar 2026 was 52.99, a 1750.91% increase from a year earlier, with the FY2025 full-year figure at 2.69, up 3556.46% from the prior year.
- Interest Coverage Ratio grew to 5.06 in Q1 2026 per RIGL's latest filing, from 3.36 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 5.06 in Q1 2026 and bottomed at 8.06 in Q1 2023.
- The 5-year median for Interest Coverage Ratio is 0.75 (2023), against an average of 0.19.
- Across the five-year window, Interest Coverage Ratio slumped 268.43% in 2022 and surged 15662.99% in 2025, its largest moves.
- Year by year, Interest Coverage Ratio stood at 1.88 in 2022, then sank by 60.24% to 0.75 in 2023, then jumped by 205.55% to 2.28 in 2024, then soared by 47.18% to 3.36 in 2025, then surged by 50.55% to 5.06 in 2026.
- Per Business Quant, the three latest RIGL Interest Coverage Ratio figures stand at 5.06 (Q1 2026), 3.36 (Q4 2025), and 1.85 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Rigel Pharmaceuticals | 674.25 Mn | 527.57 Mn | 54.21 Mn | 5.06 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.06 |
| Dec 31, 2025 | 3.36 |
| Sep 30, 2025 | 1.85 |
| Jun 30, 2025 | 3.98 |
| Mar 31, 2025 | 0.83 |
| Dec 31, 2024 | 2.28 |
| Sep 30, 2024 | 0.79 |
| Jun 30, 2024 | 0.03 |
| Mar 31, 2024 | -0.39 |
| Dec 31, 2023 | 0.75 |
| Sep 30, 2023 | -2.35 |
| Jun 30, 2023 | -2.83 |
| Mar 31, 2023 | -8.06 |
| Dec 31, 2022 | 1.88 |
| Sep 30, 2022 | -5.25 |
| Jun 30, 2022 | -2.11 |
| Mar 31, 2022 | -3.00 |
| Dec 31, 2021 | -3.28 |
| Sep 30, 2021 | -1.42 |
| Jun 30, 2021 | -0.79 |